# US 2012/0253359 A1 · Systems and methods for lead placement optimization during lead implantation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253359 A1
- Document ID: US20120253359A1
- Status: Published application
- Kind: A1
- Application number: 13/076,104
- Filed: 2011-03-30
- Published: 2012-10-04
- Earliest claimed: 2011-03-30
- Assignees: Pacesetter, Inc.
- Inventors: Steve Koh; Gene A. Bornzin
- Web page: https://patentgrep.com/patent/US20120253359A1

## CPC

- A61N 1/37241: {providing test stimulations}
- A61N 1/368: comprising more than one electrode co-operating with different heart regions {(A61N1/3622, A61N1/3627 take precedence)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Disclosed herein is a method of optimizing the implantation of an implantable medical lead into a patient to optimize electrotherapy administered via the lead. The method includes: inserting the lead into the patient, the lead including a first electrode; providing a second electrode in the patient, wherein the second electrode is not part of the lead; generating an electrical vector between the first electrode and second electrode, the electrical vector being generated as the lead is being implanted; analyzing the electrical vector as the lead is being implanted; and optimizing the implantation of the lead based off of the analysis of the electrical vector to optimize electrotherapy administered via the lead.

## Claims

### Claim 1

A method of optimizing the implantation of an implantable medical lead into a patient to optimize electrotherapy administered via the lead, the method comprising:
inserting the lead into the patient, the lead including a first electrode;
providing a second electrode in the patient, wherein the second electrode is not part of the lead;
generating an electrical vector between the first electrode and second electrode, the electrical vector being generated as the lead is being implanted;
analyzing the electrical vector as the lead is being implanted; and
optimizing the implantation of the lead based off of the analysis of the electrical vector to optimize electrotherapy administered via the lead.

### Claim 2 (depends on 1)

The method of claim 1, further comprising creating a pocket in an upper chest region of the patient and positioning the second electrode in the pocket.

### Claim 3 (depends on 2)

The method of claim 2, wherein the second electrode is a case of a pulse generator positioned in the pocket.

### Claim 4 (depends on 2)

The method of claim 2, wherein the second electrode is a temporary electrode positioned in the pocket.

### Claim 5 (depends on 4)

The method of claim 4, further comprising removing the temporary electrode from the pocket once the lead is implanted as desired, positioning a pulse generator in the pocket and coupling a proximal end of the lead to the pulse generator.

### Claim 6 (depends on 1)

The method of claim 1, further comprising providing a tubular body through which the lead is inserted into the patient and wherein the tubular body includes the second electrode.

### Claim 7 (depends on 6)

The method of claim 6, wherein the second electrode is displaceable along the tubular body.

### Claim 8 (depends on 7)

The method of claim 7, further comprising adjusting the second electrode along the tubular body to be maintained just within the patient as the tubular body is positionally adjusted within the patient during the course of implanting the lead.

### Claim 9 (depends on 8)

The method of claim 8, further comprising removing the tubular body from the patient once the lead is implanted as desired, forming a pocket in the upper chest region of the patient, positioning a pulse generator in the pocket and coupling a proximal end of the lead to the pulse generator.

### Claim 10 (depends on 1)

The method of claim 1, wherein the first electrode includes an SVC coil positioned in a SVC of the patient.

### Claim 11 (depends on 1)

The method of claim 1, wherein the electrical vector at least simulates a SVC-to-Case vector.

### Claim 12 (depends on 1)

The method of claim 1, wherein the electrical vector is analyzed with respect to extra-cardiac impedance.

### Claim 13 (depends on 1)

The method of claim 1, wherein the electrical vector includes a constant current.

### Claim 14 (depends on 1)

The method of claim 1, wherein analyzing the electrical vector as the lead is being implanted includes employing voltage as surrogate of impedance.

### Claim 15 (depends on 1)

The method of claim 1, further comprising optimizing an AVD of the analysis of the electrical vector to optimize electrotherapy administered via the lead.

### Claim 16

A method of employing extra-cardiac impedance to intra-operatively optimize lead placement, the method comprising:
during the implantation of a lead, generating an electrical vector between a lead electrode supported on the lead and another electrode not supported on the lead but at least partially positioned within a patient;
during the implantation of the lead, analyzing the electrical vector; and
guiding the implantation of the lead based at least in part off of the analysis of the electrical vector.

### Claim 17 (depends on 16)

The method of claim 16, wherein the another electrode is at least one of a case of a pulse generator or a temporary electrode positioned within a pocket formed in an upper chest region of the patient.

### Claim 18 (depends on 16)

The method of claim 16, wherein the another electrode is supported on a tubular body of an introducer catheter or sheath.

### Claim 19 (depends on 18)

The method of claim 18, wherein the another electrode is positioned within a wound in the patient leading to the subclavian vein of the patient.

### Claim 20 (depends on 16)

The method of claim 16, wherein the lead electrode includes an SVC coil positioned in a SVC of the patient.

### Claim 21 (depends on 16)

The method of claim 16, wherein the electrical vector at least simulates a SVC-to-Case vector.

### Claim 22 (depends on 16)

The method of claim 16, wherein the electrical vector is analyzed with respect to extra-cardiac impedance.

### Claim 23

A delivery tool for implanting a lead into a patient, the tool comprising:
a tubular body comprising a proximal end, a distal end, and a lumen extending longitudinally through the tubular body between the proximal end and the distal end;
a first electrode supported on the tubular body near the proximal end in such a manner that the first electrode can be displaced longitudinally along the tubular body; and
a conductor extending proximally from the electrode.

### Claim 24 (depends on 23)

The tool of claim 23, wherein the tubular body is part of an introducer sheath or a catheter.

### Claim 25 (depends on 23)

The tool of claim 23, further comprising a system coupled to a proximal end of the conductor and configured to analyze an electrical vector generated between the first electrode and an electrode of a lead delivered via the tool.

### Claim 26 (depends on 25)

The tool of claim 25, wherein the electrode of the lead is positioned in a SVC of a patient.

### Claim 27 (depends on 25)

The tool of claim 25, wherein the system analyzes the electrical vector with respect to extra-cardiac impedance.

### Claim 28

A method of optimizing an implantation of an implantable medical lead, the method comprising:
identifying a characteristic of extra cardiac impedance; and
employing the characteristic as a surrogate of cardiac output,
wherein the characteristic is monitored during lead implantation so as to position the lead to optimize cardiac output.

### Claim 29 (depends on 28)

The method of claim 28, wherein the characteristic includes at least one of Zarea, slope, max, min, or peak-to-peak.

### Claim 30 (depends on 28)

The method of claim 28, further comprising optimizing a pulse generator parameter to optimize cardiac output by monitoring the characteristic.

### Claim 31 (depends on 30)

The method of claim 30, wherein the pulse generator parameter includes at least one of AVD, V-V timing, lead configuration, or pacing mode.
